Inovio Pharmaceuticals Inc (INO)
4.07
+0.01
(+0.25%)
USD |
NASDAQ |
Nov 22, 16:00
4.08
+0.01
(+0.25%)
After-Hours: 20:00
Inovio Pharmaceuticals Cash from Investing (Quarterly): 14.08M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 14.08M |
| June 30, 2024 | 9.966M |
| March 31, 2024 | 45.38M |
| December 31, 2023 | 19.94M |
| September 30, 2023 | -5.494M |
| June 30, 2023 | 53.91M |
| March 31, 2023 | 19.00M |
| December 31, 2022 | 54.00M |
| September 30, 2022 | 44.56M |
| June 30, 2022 | -10.30M |
| March 31, 2022 | 21.33M |
| December 31, 2021 | -6.494M |
| September 30, 2021 | 55.96M |
| June 30, 2021 | 50.31M |
| March 31, 2021 | -275.12M |
| December 31, 2020 | -3.716M |
| September 30, 2020 | 39.11M |
| June 30, 2020 | -42.39M |
| March 31, 2020 | -51.81M |
| December 31, 2019 | 10.43M |
| September 30, 2019 | 8.270M |
| June 30, 2019 | 21.59M |
| March 31, 2019 | -49.34M |
| December 31, 2018 | 7.183M |
| September 30, 2018 | 14.42M |
| Date | Value |
|---|---|
| June 30, 2018 | -5.985M |
| March 31, 2018 | 26.80M |
| December 31, 2017 | 14.58M |
| September 30, 2017 | -54.16M |
| June 30, 2017 | -6.423M |
| March 31, 2017 | 18.17M |
| December 31, 2016 | 9.918M |
| September 30, 2016 | 9.073M |
| June 30, 2016 | -2.382M |
| March 31, 2016 | -0.3382M |
| December 31, 2015 | -21.22M |
| September 30, 2015 | -1.981M |
| June 30, 2015 | -29.29M |
| March 31, 2015 | -2.330M |
| December 31, 2014 | -23.22M |
| September 30, 2014 | -10.32M |
| June 30, 2014 | -2.992M |
| March 31, 2014 | 0.7186M |
| December 31, 2013 | -4.745M |
| September 30, 2013 | -0.1845M |
| June 30, 2013 | -4.318M |
| March 31, 2013 | 0.0108M |
| December 31, 2012 | 2.479M |
| September 30, 2012 | 3.443M |
| June 30, 2012 | 0.1376M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-275.12M
Minimum
Mar 2021
55.96M
Maximum
Sep 2021
2.133M
Average
16.54M
Median
Cash from Investing (Quarterly) Benchmarks
| Novavax Inc | 31.91M |
| Baxter International Inc | -164.00M |
| AIM ImmunoTech Inc | 0.334M |
| Protalix BioTherapeutics Inc | 20.33M |
| Armata Pharmaceuticals Inc | -0.34M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.44M |
| Cash from Financing (Quarterly) | 0.6606M |
| Free Cash Flow | -111.18M |
| Free Cash Flow Per Share (Quarterly) | -0.9752 |
| Free Cash Flow Yield | -107.8% |